675
Views
15
CrossRef citations to date
0
Altmetric
Studies in humans

Coffee consumption and colorectal cancer risk: a dose-response meta-analysis on prospective cohort studies

, , &
Pages 986-1006 | Received 28 Jan 2019, Accepted 03 Mar 2019, Published online: 28 Mar 2019

References

  • Alicandro G, Tavani A, La Vecchia C. 2017. Coffee and cancer risk: a summary overview. Eur J Cancer Prev. 26(5):424–432.
  • Amawi H, Ashby CR, Samuel T, Peraman R, Tiwari AK. 2017. Polyphenolic nutrients in cancer chemoprevention and metastasis: role of the epithelial-to-mesenchymal (EMT) pathway. Nutrients. 9:1–23.
  • Becker BJ, Wu M-J. 2007. The synthesis of regression slopes in meta-analysis. Statist Sci. 22(3):414–429.
  • Berretta M, Micek A, Lafranconi A, Rossetti S, Di Francia R, De Paoli P, Rossi P, Facchini G. 2018. Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies. Oncotarget. 9:20807–20815.
  • Bidel S, Hu G, Jousilahti P, Antikainen R, Pukkala E, Hakulinen T, Tuomilehto J. 2010. Coffee consumption and risk of colorectal cancer. Eur J Clin Nutr. 64(9):917–923.
  • Bohn SK, Blomhoff R, Paur I. 2014. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res. 58(5):915–930.
  • Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. 2009. Introduction to meta-analysis. Chichester, UK: Wiley.
  • Brenner H, Chen C. 2018. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 119(7):785–792.
  • Chen S, Teoh NC, Chitturi S, Farrell GC. 2014. Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection? J Gastroenterol Hepatol. 29(3):435–441.
  • Coffee, tea, mate, methylxanthines and methylglyoxal. 1991. IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 27 February to 6 March 1990. IARC Monogr Eval Carcinog Risks Hum. 51:1–513.
  • Dei Cas M, Ghidoni R. 2018. Cancer prevention and therapy with polyphenols: sphingolipid-mediated mechanisms. Nutrients. 10:1–27.
  • Deng W, Yang H, Wang J, Cai J, Bai Z, Song J, Zhang Z. 2016. Coffee consumption and the risk of incident gastric cancer-A meta-analysis of prospective cohort studies. Nutr Cancer. 68(1):40–47.
  • Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, Van Duijnhoven FJ, Cauchi S, Yengo L, Froguel P, et al. 2014. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study. Int J Cancer. 135(2):401–412.
  • Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J. 2013. Prospective study of the relationship between coffee and tea with colorectal cancer risk: the PLCO Cancer Screening Trial. Br J Cancer. 109(5):1352–1359.
  • Gan Y, Wu J, Zhang S, Li L, Cao S, Mkandawire N, Ji K, Herath C, Gao C, Xu H, et al. 2017. Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies. Oncotarget. 8:18699–18711.
  • Godos J, Micek A, Marranzano M, Salomone F, Rio DD, Ray S. 2017. Coffee consumption and risk of biliary tract cancers and liver cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients. 9:1–17.
  • Godos J, Pluchinotta FR, Marventano S, Buscemi S, Li Volti G, Galvano F, Grosso G. 2014. Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr. 65(8):925–936.
  • Greenland S. 1987. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 9:1–30.
  • Greenland S, Longnecker MP. 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 135(11):1301–1309.
  • Groessl EJ, Allison MA, Larson JC, Ho SB, Snetslaar LG, Lane DS, Tharp KM, Stefanick ML. 2016. Coffee consumption and the incidence of colorectal cancer in women. J Cancer Epidemiol. 2016:6918431.
  • Grosso G, Godos J, Galvano F, Giovannucci EL. 2017a. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 37:131–156.
  • Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Bes-Rastrollo M, Galvano F, Martinez-Gonzalez MA. 2017b. Long-term coffee consumption is associated with decreased incidence of new-onset hypertension: a dose-response meta-analysis. Nutrients. 9:1–13.
  • Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, Boffetta P. 2017c. Health risk factors associated with meat, fruit and vegetable consumption in cohort studies: a comprehensive meta-analysis. PLoS One. 12(8):e0183787.
  • Grosso G, Micek A, Godos J, Sciacca S, Pajak A, Martinez-Gonzalez MA, Giovannucci EL, Galvano F. 2016. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol. 31(12):1191–1205.
  • Hamling J, Lee P, Weitkunat R, Ambuhl M. 2008. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 27(7):954–970.
  • Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR, Albanes D. 1998. Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Nutr Cancer. 31(1):41–48.
  • Higdon JV, Frei B. 2006. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 46(2):101–123.
  • Jacobsen BK, Bjelke E, Kvale G, Heuch I. 1986. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst. 76(5):823–831.
  • Je Y, Liu W, Giovannucci E. 2009. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer. 124(7):1662–1668.
  • Kashino I, Akter S, Mizoue T, Sawada N, Kotemori A, Matsuo K, Oze I, Ito H, Naito M, Nakayama T, et al. 2018. Coffee drinking and colorectal cancer and its subsites: a pooled analysis of 8 cohort studies in Japan. Int J Cancer. 143(2):307–316.
  • Klatsky AL, Armstrong MA, Friedman GD, Hiatt RA. 1988. The relations of alcoholic beverage use to colon and rectal cancer. Am J Epidemiol. 128(5):1007–1015.
  • Lafranconi A, Micek A, De Paoli P, Bimonte S, Rossi P, Quagliariello V, Berretta M. 2018. Coffee intake decreases risk of postmenopausal breast cancer: a dose-response meta-analysis on prospective cohort studies. Nutrients. 10:1–17.
  • Lafranconi A, Micek A, Galvano F, Rossetti S, Del Pup L, Berretta M, Facchini G. 2017. Coffee decreases the risk of endometrial cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients. 9:1–13.
  • Larsson SC, Bergkvist L, Giovannucci E, Wolk A. 2006. Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol. 163:638–644.
  • Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, Group JS. 2007. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer. 121(6):1312–1318.
  • Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K. 2016. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 17(7):877–878.
  • Lukic M, Licaj I, Lund E, Skeie G, Weiderpass E, Braaten T. 2016. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study. Eur J Epidemiol. 31(9):905–916.
  • Marventano S, Salomone F, Godos J, Pluchinotta F, Del Rio D, Mistretta A, Grosso G. 2016. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: a systematic review and meta-analysis of observational studies. Clin Nutr. 35(6):1269–1281.
  • Micek A, Godos J, Lafranconi A, Marranzano M, Pajak A. 2018. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. Int J Food Sci Nutr. 69(4):417–426.
  • Michels KB, Willett WC, Fuchs CS, Giovannucci E. 2005. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst. 97(4):282–292.
  • Naganuma T, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Matsuda-Ohmori K, Shimazu T, Fukao A, Tsuji I. 2007. Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer. 120(7):1542–1547.
  • Nilsson LM, Johansson I, Lenner P, Lindahl B, Van Guelpen B. 2010. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control. 21(10):1533–1544.
  • Nkondjock A. 2009. Coffee consumption and the risk of cancer: an overview. Cancer Lett. 277(2):121–125.
  • Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S. 2006. The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer Lett. 244(2):260–267.
  • Orsini N, Bellocco R, Greenland S. 2006. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 6(1):40–57.
  • Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. 2012. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 175(1):66–73.
  • Perrigue MM, Kantor ED, Hastert TA, Patterson R, Potter JD, Neuhouser ML, White E. 2013. Eating frequency and risk of colorectal cancer. Cancer Causes Control. 24(12):2107–2115.
  • Peterson S, Yuan JM, Koh WP, Sun CL, Wang R, Turesky RJ, Yu MC. 2010. Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study. Nutr Cancer. 62(1):21–29.
  • Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. 2017. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 359:j5024.
  • Ranheim T, Halvorsen B. 2005. Coffee consumption and human health-beneficial or detrimental?-Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res. 49(3):274–284.
  • Simons CC, Leurs LJ, Weijenberg MP, Schouten LJ, Goldbohm RA, van den Brandt PA. 2010. Fluid intake and colorectal cancer risk in the Netherlands Cohort Study. Nutr Cancer. 62(3):307–321.
  • Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND. 2012. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr. 96(2):374–381.
  • Stensvold I, Jacobsen BK. 1994. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control. 5(5):401–408.
  • Stukel TA, Demidenko E. 1997. Two-stage method of estimation for general linear growth curve models. Biometrics. 53(2):720–728.
  • Terry P, Bergkvist L, Holmberg L, Wolk A. 2001. Coffee consumption and risk of colorectal cancer in a population based prospective cohort of Swedish women. Gut. 49(1):87–90.
  • Tian C, Wang W, Hong Z, Zhang X. 2013. Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer Causes Control. 24(6):1265–1268.
  • Vitaglione P, Fogliano V, Pellegrini N. 2012. Coffee, colon function and colorectal cancer. Food Funct. 3(9):916–922.
  • Wierzejska R. 2015. Coffee consumption vs. cancer risk - a review of scientific data. Rocz Panstw Zakl Hig. 66(4):293–298.
  • Wu AH, Paganini-Hill A, Ross RK, Henderson BE. 1987. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer. 55(6):687–694.
  • Wu QJ, Xie L, Zheng W, Vogtmann E, Li HL, Yang G, Ji BT, Gao YT, Shu XO, Xiang YB. 2013. Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta-analysis. Ann Oncol. 24(7):1918–1924.
  • Yamada H, Kawado M, Aoyama N, Hashimoto S, Suzuki K, Wakai K, Suzuki S, Watanabe Y, Tamakoshi A, Group JS. 2014. Coffee consumption and risk of colorectal cancer: the Japan Collaborative Cohort Study. J Epidemiol. 24(5):370–378.
  • Yamagata K. 2018. Do coffee polyphenols have a preventive action on metabolic syndrome associated endothelial dysfunctions? an assessment of the current evidence. Antioxidants (Basel). 7:1–18.
  • Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, Flood A, Freudenheim JL, Giovannucci EL, Goldbohm RA, Jaceldo-Siegl K, et al. 2010. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst. 102(11):771–783.
  • Zhang Y, Zhang DZ. 2018. Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies. Int J Food Sci Nutr. 69(8):1003–1012.
  • Zhang Y, Zhang DZ. 2018. Is coffee consumption associated with a lower level of serum C-reactive protein? A meta-analysis of observational studies. Int J Food Sci Nutr. 69(8):985–994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.